{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:54:48Z","timestamp":1788184488496,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 HL140025"],"award-info":[{"award-number":["R35 HL140025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL101972"],"award-info":[{"award-number":["HL101972"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL126235"],"award-info":[{"award-number":["HL126235"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL144113"],"award-info":[{"award-number":["HL144113"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jtha.2022.12.014","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T06:55:15Z","timestamp":1673160915000},"page":"1200-1213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Titanium is a potent inducer of contact activation: implications for intravascular devices"],"prefix":"10.1016","volume":"21","author":[{"given":"Maxim","family":"Litvak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Shamanaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Zalawadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Matafonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Kobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Feener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wallisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik I.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen J.T.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.12.014_bib1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.msec.2005.08.032","article-title":"Titanium alloys for biomedical applications","volume":"26","author":"Rack","year":"2006","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.jtha.2022.12.014_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s42242-021-00170-3","article-title":"A\u00a0state-of-the-art review of the fabrication and characteristics of titanium and its alloys for biomedical applications","volume":"5","author":"Sarraf","year":"2021","journal-title":"Biodes Manuf"},{"key":"10.1016\/j.jtha.2022.12.014_bib3","doi-asserted-by":"crossref","first-page":"E660","DOI":"10.21037\/jtd.2016.07.13","article-title":"Left ventricular assist devices\u2014current state and perspectives","volume":"8","author":"Prinzing","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtha.2022.12.014_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/bioengineering8120215","article-title":"control of blood coagulation by hemocompatible material surfaces\u2014a review","volume":"8","author":"Kuchinka","year":"2021","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.jtha.2022.12.014_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-0037-1614630","article-title":"Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis","volume":"82","author":"Hong","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biomaterials.2004.05.036","article-title":"Material-specific thrombin generation following contact between metal surfaces and whole blood","volume":"26","author":"Hong","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtha.2022.12.014_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biomaterials.2006.10.020","article-title":"The role of whole blood in thrombin generation in contact with various titanium surfaces","volume":"28","author":"Thor","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtha.2022.12.014_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jbm.a.34006","article-title":"Adhesion, activation, and aggregation of blood platelets and biofilm formation on the surfaces of titanium alloys Ti6Al4V and Ti6Al7Nb","volume":"100","author":"Walkowiak-Przyby\u0142o","year":"2012","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.jtha.2022.12.014_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biomaterials.2015.01.031","article-title":"TiO2 nanoparticles tested in a novel screening whole human blood model of toxicity trigger adverse activation of the kallikrein system at low concentrations","volume":"51","author":"Ekstrand-Hammarstr\u00f6m","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtha.2022.12.014_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fbioe.2019.00170","article-title":"Titanium-tissue interface reaction and its control with surface treatment","volume":"7","author":"Hanawa","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jtha.2022.12.014_bib11","unstructured":"Malone G, Abdelsayed G, Bligh F, al Qattan F, Syed S, Varatharajullu P, Msellati A, Mwipatayi D, Azhar M, Malone A, Fatimi SH, Conway C, Hameed A. Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy. J Anat (in press)."},{"key":"10.1016\/j.jtha.2022.12.014_bib12","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jocs.15341","article-title":"Left ventricular assist devices: A comprehensive review of major clinical trials, devices, and future directions","volume":"36","author":"Jefferson","year":"2021","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.jtha.2022.12.014_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/039139889201501009","article-title":"Hemocompatibility of titanium nitride","volume":"15","author":"Dion","year":"1992","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jtha.2022.12.014_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jbm.a.36635","article-title":"Revolutionary advances in 2-methacryloyloxyethyl phosphorylcholine polymers as biomaterials","volume":"107","author":"Ishihara","year":"2019","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.jtha.2022.12.014_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000517454","article-title":"Stroke in patients with left ventricular assist devices","volume":"51","author":"Plecash","year":"2022","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jtha.2022.12.014_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1540-8191.2012.01504.x","article-title":"The spectrum of complications following left ventricular assist device placement","volume":"27","author":"Yuan","year":"2012","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.jtha.2022.12.014_bib17","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1161\/CIRCULATIONAHA.111.040246","article-title":"Bleeding and thrombosis in patients with continuous-flow ventricular assist devices","volume":"125","author":"Eckman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2022.12.014_bib18","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.ajem.2019.04.050","article-title":"Left ventricular assist devices and their complications: A review for emergency clinicians","volume":"37","author":"Long","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jtha.2022.12.014_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2017-000250","article-title":"Improving anticoagulation of patients with an implantable left ventricular assist device","volume":"7","author":"Sage","year":"2018","journal-title":"BMJ Open Qual"},{"key":"10.1016\/j.jtha.2022.12.014_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/14779072.2020.1773803","article-title":"Anticoagulant treatment and bleeding complications in patients with left ventricular assist devices","volume":"18","author":"den Exter","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jtha.2022.12.014_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: an interface between inflammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib23","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1213\/ANE.0b013e3182354b7e","article-title":"Activation of the hemostatic system during cardiopulmonary bypass","volume":"113","author":"Sniecinski","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2022.12.014_bib24","doi-asserted-by":"crossref","first-page":"222ra17","DOI":"10.1126\/scitranslmed.3006804","article-title":"A\u00a0factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtha.2022.12.014_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/rth2.12309","article-title":"Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates","volume":"4","author":"Wallisch","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrneph.2017.17","article-title":"Cardiovascular disease in haemodialysis: role of the intravascular innate immune system","volume":"13","author":"Ekdahl","year":"2017","journal-title":"undefined Nat Rev Nephrol"},{"key":"10.1016\/j.jtha.2022.12.014_bib27","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.biomaterials.2006.11.005","article-title":"Blood plasma contact activation on silicon, titanium and aluminum","volume":"28","author":"Arvidsson","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtha.2022.12.014_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.actbio.2021.10.022","article-title":"Reduced thrombogenicity of surface-treated nitinol implants steered by altered protein adsorption","volume":"137","author":"Gegenschatz-Schmid","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jtha.2022.12.014_bib29","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1167\/iovs.15-18272","article-title":"Plasma kallikrein mediates vascular endothelial growth factor\u2013induced retinal dysfunction and thickening","volume":"57","author":"Clermont","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtha.2022.12.014_bib30","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1182\/blood.2021012945","article-title":"A\u00a0mechanism for hereditary angioedema caused by a lysine 311-to-glutamic acid substitution in plasminogen","volume":"139","author":"Dickeson","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib31","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1021\/acssuschemeng.8b01151","article-title":"Kaolin: A natural low-cost material as catalyst for isomerization of glucose to fructose","volume":"6","author":"Pienko\u00df","year":"2018","journal-title":"ACS Sustain Chem Eng"},{"key":"10.1016\/j.jtha.2022.12.014_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2008-06-163675","article-title":"Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI","volume":"113","author":"Tucker","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12195-020-00657-6","article-title":"Development of coagulation factor XII antibodies for inhibiting vascular device-related thrombosis","volume":"14","author":"Kohs","year":"2021","journal-title":"Cell Mol Bioeng"},{"key":"10.1016\/j.jtha.2022.12.014_bib34","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A\u00a0role for factor XIIa-mediated factor XI activation in thrombus formation in\u00a0vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib35","doi-asserted-by":"crossref","first-page":"23596","DOI":"10.1074\/jbc.M114.569061","article-title":"Inhibition of plasma kallikrein by a highly specific active site blocking antibody","volume":"289","author":"Kenniston","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.12.014_bib36","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2016-10-744110","article-title":"Proteolytic properties of single-chain factor XII: A mechanism for triggering contact activation","volume":"129","author":"Ivanov","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib37","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/bloodadvances.2021005976","article-title":"Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains","volume":"6","author":"Shamanaev","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.12.014_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0267-6605(92)90056-Y","article-title":"Physico-chemical considerations of titanium as a biomaterial","volume":"9","author":"Tengvall","year":"1992","journal-title":"Clin Mater"},{"key":"10.1016\/j.jtha.2022.12.014_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/cr60234a002","article-title":"The isoelectric points of solid oxides, solid hydroxides, and aqueous hydroxo complex systems","volume":"65","author":"Parks","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtha.2022.12.014_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/jcis.2000.6847","article-title":"Surface charge of silver iodide and several metal oxides. are all surfaces Nernstian?","volume":"227","author":"Larson","year":"2000","journal-title":"J\u00a0Colloid Interface Sci"},{"key":"10.1016\/j.jtha.2022.12.014_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.procbio.2012.02.010","article-title":"Surface modification of iron oxide nanoparticles with polyarginine as a highly positively charged magnetic nano-adsorbent for fast and effective recovery of acid proteins","volume":"47","author":"Lai","year":"2012","journal-title":"Proc Biochem"},{"key":"10.1016\/j.jtha.2022.12.014_bib42","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1515\/hsz-2013-0144","article-title":"Zinc-dependent contact system activation induces vascular leakage and hypotension in rodents","volume":"394","author":"Bjorkqvist","year":"2013","journal-title":"Biol Chem"},{"key":"10.1016\/j.jtha.2022.12.014_bib43","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jth.14964","article-title":"Cationic zinc is required for factor XII recruitment and activation by stimulated platelets and for thrombus formation in\u00a0vivo","volume":"18","author":"Chaudhry","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V55.1.156.156","article-title":"Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces","volume":"55","author":"Vroman","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2017.10.008","article-title":"An update on factor XI structure and function","volume":"161","author":"Mohammed","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.12.014_bib46","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M707234200","article-title":"Characterization of novel forms of coagulation factor XIa: independence of factor XIa subunits in factor IX activation","volume":"283","author":"Smith","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.12.014_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOH.0000000000000727","article-title":"Recent advances in factor XII structure and function","volume":"29","author":"Shamanaev","year":"2022","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2022.12.014_bib48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0039-3402760","article-title":"The fibronectin type II domain of factor XII ensures zymogen quiescence","volume":"120","author":"Clark","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib49","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1182\/bloodadvances.2020002456","article-title":"The evolution of factor XI and the kallikrein-kinin system","volume":"4","author":"Ponczek","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.12.014_bib50","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/204701b0","article-title":"Ellipsometer recordings of changes in optical thickness of adsorbed films associated with surface activation of blood clotting","volume":"204","author":"Vroman","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2022.12.014_bib51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-1003477","article-title":"The importance of surfaces in contact phase reactions","volume":"13","author":"Vroman","year":"1987","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0142-9612(93)90222-N","article-title":"Haemocompatibility of TI6A14V alloy","volume":"14","author":"Dion","year":"1993","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtha.2022.12.014_bib53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/15376516.2011.610384","article-title":"Pre-clinical evaluation of titanium nitride coated titanium material","volume":"22","author":"Geetha","year":"2012","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.jtha.2022.12.014_bib54","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4236\/jmmce.2011.1011077","article-title":"Significance of impurity mineral identification in the value addition of kaolin\u2014a case study with reference to an acidic kaolin from India","volume":"10","author":"Ramaswamy","year":"2011","journal-title":"JMMCE"},{"key":"10.1016\/j.jtha.2022.12.014_bib55","series-title":"A\u00a0study of mineral impurities within the Georgia kaolins","author":"Gardner","year":"2016"},{"key":"10.1016\/j.jtha.2022.12.014_bib56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0036-1598003","article-title":"Factor XII contact activation","volume":"43","author":"Naudin","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib57","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/j.1538-7836.2012.04890.x","article-title":"Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation","volume":"10","author":"Mutch","year":"2012","journal-title":"J\u00a0Thromb Haemostas"},{"key":"10.1016\/j.jtha.2022.12.014_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12659\/MSMBR.894840","article-title":"Continuous-flow left ventricular assist device thrombosis: a danger foreseen is a danger avoided","volume":"21","author":"Fatullayev","year":"2015","journal-title":"Med Sci Monit Basic Res"},{"key":"10.1016\/j.jtha.2022.12.014_bib59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MAT.0000000000000388","article-title":"Design rationale and preclinical evaluation of the HeartMate 3 Left Ventricular Assist System for hemocompatibility","volume":"62","author":"Bourque","year":"2016","journal-title":"Am Soc Artificial Int Organs"},{"key":"10.1016\/j.jtha.2022.12.014_bib60","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1594.2006.00276.x","article-title":"In\u00a0vivo assessment of a rotary left ventricular assist device-induced artificial pulse in the proximal and distal aorta","volume":"30","author":"Bourque","year":"2006","journal-title":"Artificial Organs"},{"key":"10.1016\/j.jtha.2022.12.014_bib61","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A\u00a0fully magnetically levitated left ventricular assist device-final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.12.014_bib62","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","article-title":"Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding","volume":"134","author":"Tabit","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2022.12.014_bib64","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.V99.5.1646","article-title":"Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib65","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1538-7836.2010.03812.x","article-title":"Thrombin upregulates the angiopoietin-Tie2 axis: endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P-selectin from Weibel-Palade bodies","volume":"8","author":"Bae","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib66","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MAT.0000000000001534","article-title":"Surface coatings for rotary ventricular assist devices: a systematic review","volume":"68","author":"Zhang","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.jtha.2022.12.014_bib67","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(21)02436-3","article-title":"Prophylaxis with anti-activated factor XII for hereditary angioedema","volume":"399","author":"Fijen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2022.12.014_bib68","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(21)02225-X","article-title":"Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"399","author":"Craig","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2022.12.014_bib69","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1182\/blood-2011-05-355248","article-title":"Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding","volume":"118","author":"Revenko","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib70","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in\u00a0vivo","volume":"139","author":"M\u00fcller","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2022.12.014_bib71","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/ATVBAHA.118.312328","article-title":"Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial","volume":"39","author":"Lorentz","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2022.12.014_bib72","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood.2021011725","article-title":"The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial","volume":"138","author":"Lorentz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib73","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1405760","article-title":"Factor XI antisense oligonucleotide for prevention of venous thrombosis","volume":"372","author":"B\u00fcller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.12.014_bib74","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.2019.20687","article-title":"Effect of osocimab in preventing venous thromboembolism among patients undergoing knee arthroplasty: the foxtrot randomized clinical trial","volume":"323","author":"Weitz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2022.12.014_bib75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for prevention of venous thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.12.014_bib76","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa2113194","article-title":"Milvexian for the prevention of venous thromboembolism","volume":"385","author":"Weitz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.12.014_bib77","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1111\/jth.15890","article-title":"Achieving higher efficacy without compromising safety with Factor XI inhibitors versus low-molecular-weight heparin for the prevention of venous thromboembolism in major orthopedic surgery - Systematic Review and Meta-Analysis.","volume":"20","author":"Presume","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.014_bib78","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.12.014_bib79","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/blood-2007-10-120139","article-title":"Reduced incidence of ischemic stroke in patients with severe factor XI deficiency","volume":"111","author":"Salomon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.014_bib80","unstructured":"Shoamanesh A, Mundl H, Smith EE, Masjuan J, Milanov I, Hirano T, Agafina A, Campbell B, Caso V, Mas JL, Dong Q, Turcani P, Christensen H, Ferro JM, Veltkamp R, Mikulik R, De Marchis GM, Robinson T, Lemmens R, Stepien A, et\u00a0al. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet (in press)."},{"key":"10.1016\/j.jtha.2022.12.014_bib81","article-title":"Hankey G for the AXIOMATIC-SSP Steering Committee and Investigators. Efficacy and safety of the FXIa inhibitor milvexian for secondary stroke prevention: final results of the AXIOMATIC-SSP dose-finding randomization trial","author":"Sharma","year":"2022","journal-title":"Presented at a Hot Line session at the European Society of Cardiology Congress"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362218253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362218253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:12Z","timestamp":1761536232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362218253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S153878362218253X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.12.014","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Titanium is a potent inducer of contact activation: implications for intravascular devices","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}